Table 3. Biomarker selection in set 1.
| Marker | Avg.Imp | Rank | P-value |
|---|---|---|---|
| EGFR | 30.13 | 1 | 0.000 |
| ApoA1/proApoA1 | 29.70 | 2 | 0.000 |
| TTR | 29.17 | 3 | 0.000 |
| proApoA1 | 26.89 | 4 | 0.000 |
| RANTES | 26.78 | 5 | 0.000 |
| ApoA1 | 25.35 | 6 | 0.000 |
| ApoA2 | 24.60 | 7 | 0.000 |
| DD | 24.03 | 8 | 0.000 |
| VN | 23.61 | 9 | 0.000 |
| IL-6 | 18.71 | 10 | 0.000 |
| CRP | 18.47 | 11 | 0.000 |
| A2M | 17.25 | 12 | 0.000 |
| PAI-1 | 16.80 | 13 | 0.000 |
| ApoC3 | 16.31 | 14 | 0.000 |
| ApoC2 | 15.24 | 15 | 0.000 |
| fPSA | 14.08 | 16 | 0.118 |
| VDBP | 13.24 | 17 | 0.000 |
| AFP | 12.98 | 18 | 0.004 |
| Hp | 11.73 | 19 | 0.043 |
| sVCAM-1 | 11.37 | 20 | 0.000 |
| DKK3 | 10.94 | 21 | 0.000 |
| ApoA4 | 9.45 | 22 | 0.309 |
| CA19-9 | 9.13 | 23 | 0.525 |
| A1AT | 8.99 | 24 | 0.349 |
| Hemo | 8.96 | 25 | 0.663 |
| PSA | 8.24 | 26 | 0.404 |
| sICAM-1 | 7.77 | 27 | 0.702 |
| fPSA/tPSA | 7.16 | 28 | 0.875 |
| CA125 | 6.84 | 29 | 0.401 |
| CEA | 6.29 | 30 | 0.877 |
| B2M | 5.79 | 31 | 0.962 |
Abbreviations: AFP=α-fetoprotein; Apo=apolipoprotein; A1AT=α-1-antitrypin; A2M=α-2 macroglobulin; β 2M=β2-microglobulin; CA=cancer antigen; CEA=carcinoembryonic antigen; CRP=C-reactive protein; DD=D-dimer; DKK.3=Dickkopf 3; EGFR=epidermal growth factor receptor; fPSA=free prostate-specific antigen; Hp=Haptoglobin α; IL=interleukin; PAI-1=plasminogen activator inhibitor-1; proApo=pro-apolipoprotein; PSA=prostate-specific antigen; RANTES=regulated upon activation, normally T-expressed and presumably secreted; sICAM=soluble intercellular cell adhesion molecule-1; sVCAM=soluble vascular cell adhesion molecule-1; tPSA=total prostate-specific antigen; TTR=transthyretin; VDBP=vitamin D-binding protein; VN=vitronectin.